The 80-125% rule ensures generic drugs are as safe and effective as brand-name versions by measuring how much of the drug enters your bloodstream. It's based on statistical confidence intervals, not pill content.
Despite generics making up 90% of prescriptions, most doctors receive little training on bioequivalence. This article explores why physicians still doubt generic drugs and what medical education must change to close the knowledge-behavior gap.
Clinical outcomes data shows generic drugs are just as effective and safe as brand-name medications for most conditions. Providers can confidently prescribe generics to improve adherence and reduce costs without compromising care.